AcelRx Pharma (ACRX) Stock Trading Halted Ahead of FDA Advisory Committee to Review DSUVIA NDA

October 12, 2018 7:11 AM
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot FDA News Trading Halts

Next Articles